Skip navigation
MOST POPULAR RELATED TAGS
  • TOPICS
  • SECTORS
  • COMPANIES

RSS FEED

» Help

Current DateTime: 05:48:03 29 Nov 2009
LinksList Documentid: 30328029

CNBC Stock Blog

Text Size
Feb.25
2:05 PM ET
Wednesday, 25 Feb 2009
Options 'Aggressively' Target Pharma Services Co.

Traders are aggressively buying calls in Omnicare ahead of its earnings report Thursday morning.

Shares of the geriatric pharmaceutical services company are falling today along with the broader markets, but its March calls are trading higher. The buying is focused on the March 30 calls, which traded more than 5,000 contracts this morning mostly for $1.05, according to OptionMonster's tracking systems.

OCR stock [OCR  Loading...      ()   ] is down some 5 percent in midday trading to just under $27. It has been on a roller-coaster ride since its highs over $32 in September to lows under $20 in October, but the stock has been solid recently as the company declared a quarterly cash dividend earlier this month.

___________________________________
Other Pharma Benefits Managers:

CVS Caremark [CVS  Loading...      ()   ]

MedcoHealth Solutions  [MHS  Loading...      ()   ]

Express Scripts  [ESRX  Loading...      ()   ]

___________________________________

Pete Najarian is a professional investor, CNBC contributor, regular co-host of CNBC's "Fast Money" and co-founder of OptionMonster.com.

___________________________________

Disclaimer

© 2009 CNBC.com

Tools:
PrintEmailAdd This share icon
Next Post
  • digg share
ADD COMMENTS
Remaining characters


Current DateTime: 01:00:33 29 Nov 2009
LinksList Documentid: 29778428

Current DateTime: 01:06:46 29 Nov 2009
LinksList Documentid: 29779196

Current DateTime: 01:06:46 29 Nov 2009
LinksList Documentid: 29779199

Current DateTime: 01:08:01 29 Nov 2009
LinksList Documentid: 29779198
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2009 CNBC, Inc.  All Rights Reserved.
A Division of NBC Universal
Thomson ReutersThomson Reuters